Novartis AG
NVS News Today: Stay Updated with the Latest Novartis AG News in Real Time
Find NVS news now at Meyka AI. Stay informed with the latest Novartis AG stocks updates, including price news, market analysis, and expert insights.
Down 6.09% pre-market: MOLN.SW Molecular Partners AG (SIX) 23 Feb 2026, catalysts
Pre-market top loser MOLN.SW stock down 6.09% at CHF 3.94; pipeline catalysts and Meyka AI forecast show downside risk
NOVARTIND.BO up 20.00% pre-market at INR 996.50: 21 Feb 2026 top gainer outlook
Pre-market top gainer NOVARTIND.BO stock at INR 996.50 on 21 Feb 2026; Meyka AI forecast and analyst view
Sandoz Group (SDZ.SW, SIX) pre-market CHF67.04 21 Feb 2026 earnings: margins
SDZ.SW stock trades CHF67.04 pre-market on 21 Feb 2026 ahead of earnings; we flag margins, PE 167.60 and a Meyka AI forecast to CHF81.59
NOVN.SW Novartis (SIX) closed CHF126.48 19 Feb 2026: remibrutinib supports outlook
NOVN.SW stock closed CHF126.48 on 19 Feb 2026; remibrutinib data and cash flow shape Meyka AI forecast for Novartis
SDZ.SW Sandoz Group AG (SIX) market closed 18 Feb 2026: CHF66.68 shows momentum signal
SDZ.SW stock at CHF66.68 on 18 Feb 2026. Meyka AI forecast CHF81.59 and grade B. Key metrics, risks, and trading signals for investors
CHF128.30 Novartis AG (NOVN.SW) on SIX intraday: most active stock signals momentum
NOVN.SW stock trades at CHF128.30 intraday on 17 Feb 2026 with strong volume and overbought technicals
IGPH.SW down 25% to CHF0.0015 on heavy volume (SIX) 17 Feb 2026: intraday most active
Intraday: IGPH.SW stock falls to CHF0.0015 on heavy volume; Meyka AI grade, valuation and 12-month forecast
MOLN.SW Molecular Partners AG (SIX) up 6.16% pre-market 17 Feb 2026: catalysts may extend gains
Pre-market update on MOLN.SW stock: **CHF 3.62**, +6.16%, Meyka AI grade and forecast for investors
CYAD.BR Celyad Oncology EURONEXT +34.93% intraday 16 Feb 2026: high-volume alert
CYAD.BR stock jumps on heavy volume; intraday analysis, Meyka AI grade and forecast for Celyad Oncology (EURONEXT)